Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
5.09
+0.09 (1.80%)
Mar 23, 2026, 4:00 PM EDT - Market closed
Foghorn Therapeutics Employees
Foghorn Therapeutics had 106 employees as of December 31, 2025. The number of employees decreased by 6 or -5.36% compared to the previous year.
Employees
106
Change (1Y)
-6
Growth (1Y)
-5.36%
Revenue / Employee
$291,594
Profits / Employee
-$700,783
Market Cap
298.78M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 106 | -6 | -5.36% |
| Dec 31, 2024 | 112 | -4 | -3.45% |
| Dec 31, 2023 | 116 | -45 | -27.95% |
| Dec 31, 2022 | 161 | 42 | 35.29% |
| Dec 31, 2021 | 119 | 24 | 25.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 305 |
| AC Immune | 172 |
| Neurogene | 107 |
| Armata Pharmaceuticals | 60 |
| Crescent Biopharma | 44 |
| ALX Oncology Holdings | 43 |
| Surrozen | 41 |
| NovaBridge Biosciences | 32 |
FHTX News
- 12 days ago - Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook - GlobeNewsWire
- 4 weeks ago - Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer - GlobeNewsWire
- 7 weeks ago - Foghorn Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit - GlobeNewsWire
- 2 months ago - Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium - GlobeNewsWire
- 2 months ago - Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026 - GlobeNewsWire
- 4 months ago - Foghorn Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference - GlobeNewsWire
- 4 months ago - Foghorn Therapeutics Provides Third Quarter 2025 Financial and Corporate Update - GlobeNewsWire